NCT06315855 F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
| NCT ID | NCT06315855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgetown University |
| Condition | Oral Mucositis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2026-08-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-08-20 with a primary completion date of 2026-08-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will conduct a 2-arm 6-month randomized clinical controlled trial to evaluate the effectiveness of an oral Telehealth Intervention (THI) in preventing cancer-related oral complications, improving oral health maintenance and oral health related quality of life, and reducing systemic inflammation compared to Usual Care (UC) among unselected cancer survivors.
Eligibility Criteria
Inclusion Criteria: * male and female cancer survivors who are either ≥ 6 months after competing primary therapy for cancer treatment (N=100) * between 25-75 years of age * all race/ethnic groups * own a smart phone. Exclusion Criteria: * all head and neck/oral cancer survivors * less then 25 years and older than 75 years of age * recurrence/second cancers or undergoing treatment * unable to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06315855 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 75 Years, studying Oral Mucositis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06315855 currently recruiting?
Yes, NCT06315855 is actively recruiting participants. Contact the research team at ds1924@georgetown.edu for enrollment information.
Where is the NCT06315855 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT06315855 clinical trial?
NCT06315855 is sponsored by Georgetown University. The trial plans to enroll 100 participants.